Prot #ALN-TTR02-006: A Multicenter, Open-Label, Extension Study to Evaluate the Long-Term Safety and Efficacy of Patisiran in Patients with Familial Amyloidotic Polyneuropathy who have Completed a Prior Clinical Study with Patisiran

Project: Research project

Project Details

StatusFinished
Effective start/end date2/18/162/20/23

Funding

  • Medpace, Inc. (Prot #ALN-TTR02-006)
  • Alnylam Pharmaceuticals, Inc. (Prot #ALN-TTR02-006)